14-104714242-C-T
Variant summary
Our verdict is Benign. Variant got -7 ACMG points: 0P and 7B. BP4_ModerateBP6BS2
The NM_022489.4(INF2):c.3080C>T(p.Thr1027Met) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000197 in 1,572,732 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_022489.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -7 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
INF2 | NM_022489.4 | c.3080C>T | p.Thr1027Met | missense_variant | 21/23 | ENST00000392634.9 | NP_071934.3 | |
INF2 | NM_001031714.4 | c.3080C>T | p.Thr1027Met | missense_variant | 21/22 | NP_001026884.3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
INF2 | ENST00000392634.9 | c.3080C>T | p.Thr1027Met | missense_variant | 21/23 | 5 | NM_022489.4 | ENSP00000376410 | P4 |
Frequencies
GnomAD3 genomes AF: 0.0000197 AC: 3AN: 152202Hom.: 0 Cov.: 34
GnomAD3 exomes AF: 0.0000313 AC: 6AN: 191562Hom.: 0 AF XY: 0.0000480 AC XY: 5AN XY: 104176
GnomAD4 exome AF: 0.0000197 AC: 28AN: 1420530Hom.: 0 Cov.: 69 AF XY: 0.0000228 AC XY: 16AN XY: 703222
GnomAD4 genome AF: 0.0000197 AC: 3AN: 152202Hom.: 0 Cov.: 34 AF XY: 0.0000134 AC XY: 1AN XY: 74358
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Athena Diagnostics | Sep 06, 2016 | - - |
Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Sep 07, 2023 | The c.3080C>T (p.T1027M) alteration is located in exon 21 (coding exon 20) of the INF2 gene. This alteration results from a C to T substitution at nucleotide position 3080, causing the threonine (T) at amino acid position 1027 to be replaced by a methionine (M). This amino acid position is not well conserved in available vertebrate species. The alteration is predicted benign by in silico models:_x000D_ _x000D_ The p.T1027M alteration is predicted to be benign by Polyphen and tolerated by SIFT in silico analyses. Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Focal segmental glomerulosclerosis 5;C4302667:Charcot-Marie-Tooth disease dominant intermediate E Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Apr 19, 2023 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at